How much symptom overlap is there between microscopic colitis and IBS? Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 6, 2007, Pages 304-305

  Fernández Bañares, Fernando ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT;

ABDOMINAL PAIN; COLON BIOPSY; COLONOSCOPY; DEFECATION URGENCY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; FECES INCONTINENCE; FLATULENCE; HUMAN; IRRITABLE COLON; MICROSCOPIC COLITIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RECTUM BIOPSY; RISK FACTOR; SHORT SURVEY; SIGMOIDOSCOPY; SYMPTOMATOLOGY;

EID: 34548559316     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0814     Document Type: Short Survey

References (5)

1. Fernández-Bañares F et al. (2003) Collagenous and lymphocytic colitis: Evaluation of clinical and histological features, response to treatment, and long-term follow up. Am J Gastroenterol 98: 340-347
2. Nyhlin N et al. (2006) Systematic review: Microscopic colitis. Aliment Pharmacol Ther 23: 1525-1534
3. Madisch A et al.(2005) Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 20: 312-316
4. Chande N et al. Interventions for treating collagenous colitis. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003575.pub4. doi:10.1002/14651858.CD003575.pub4
5. Thompson WG et al. (2000) Functional bowel disorders and functional abdominal pain. In Rome II: The functional gastrointestinal disorders: DiagnosisA pathophysiology, and treatment: a multinational consensus, 351-432 (Eds Drossman DA et al.) McLean: Degnon associates